Report cover image

U.S. Digital Therapeutics Market

Published Aug 20, 2025
Length 157 Pages
SKU # CMI20399672

Description

Digital therapeutics (DTx) are evidence-based therapeutic interventions, driven by the high quality software programs, to prevent, manage, or treat a medical disorder or disease. DTx have potential to reduce disease burdens, deliver better clinical outcomes, and improve patients’ lives by offering better ways to manage chronic health conditions.

Market Dynamics

Rise in burden of chronic diseases, outbreak of COVID-19 (pandemic), growing adoption of digital healthcare, rise in adoption of novel technologies, and favorable government initiatives (support) are major factors expected to augment growth of the US digital therapeutics market.

For instance, in September 2022, the U.S. Food & Drug Administration (USFDA) announced the launch of the Digital Health Center of Excellence within the Center for Devices and Radiological Health (CDRH). The launch of the Digital Health Center of Excellence is a vital step in furthering the agency’s overarching dedication to the advancement of digital health technology, including mobile health devices, Software as a Medical Device (SaMD), wearables when used as a medical device, and technologies used to study medical products.

Key features of the study
  • This report provides in-depth analysis of the US digital therapeutics market, and provides market size (USD Bn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the US digital therapeutics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include 2Morrow Inc., ResMed, Pear Therapeutics, Omada Health Inc., Teladoc Health, Lark Technologies, Kaia Health, Fitbit, Cognoa Inc., and Akili Interactive Labs, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The US digital therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the US digital therapeutics market.
Market Segmentation
  • U.S. Digital Therapeutics Market, By Application
  • Treatment & Disease Management
  • Chronic Care
  • Mental Health & Neurological Disorders
  • Others
  • Preventive Care
  • Pre-diabetes
  • Weight Management
  • Others
  • U.S. Digital Therapeutics Market, By End User
  • Healthcare Providers
  • Patients/Individuals
  • Payers
  • Employers
  • Others
  • Company Profiles
  • 2Morrow Inc.
  • ResMed
  • Pear Therapeutics
  • Omada Health Inc.
  • Teladoc Health
  • Lark Technologies
  • Kaia Health
  • Fitbit
  • Cognoa Inc.
  • Akili Interactive Labs

Table of Contents

157 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Application
Market Snapshot, By End User
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Growing adoption of digital healthcare/technologies
Growing concerns about patient data privacy
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. U.S. Digital Therapeutics Market, By Application, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Treatment & Disease Management
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 -2032, (USD Bn)
Chronic Care
Mental Health & Neurological Disorders
Others
Preventive Care
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pre-diabetes
Weight Management
Others
5. U.S. Digital Therapeutics Market, By End User, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Healthcare Providers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Patients/Individuals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Payers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Employers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Competitive Landscape
2Morrow Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
ResMed
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Pear Therapeutics
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Omada Health Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Teladoc Health
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Lark Technologies
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Kaia Health
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Fitbit
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Cognoa Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Akili Interactive Labs
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Analyst Views
7. Section
Research Methodology
About us
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.